Acorda Says Tribunal Ignored Patent Law In MS Drug Feud
By Caroline Simson · March 19, 2024, 8:39 PM EDT
Acorda Pharmaceuticals is pressing the Federal Circuit to award it nearly $66 million more than the $16.5 million it won in arbitration against Irish biopharmaceutical company Alkermes in a licensing fight...
To view the full article, register now.